Uterine Serous Papillary Carcinoma: A Retrospective Analysis of 22 Cases

Authors

  • Demir Özbasar Maternity and Women’s Health Teaching Research Hospital, Gynecologic Oncology Division, Ankara
  • Serap Bozok Maternity and Women’s Health Teaching Research Hospital, Gynecologic Oncology Division, Ankara
  • Taner Turan Maternity and Women’s Health Teaching Research Hospital, Gynecologic Oncology Division, Ankara
  • İltac Küçükelçi Maternity and Women’s Health Teaching Research Hospital, Gynecologic Oncology Division, Ankara
  • Gökhan Tulunay Maternity and Women’s Health Teaching Research Hospital, Gynecologic Oncology Division, Ankara
  • Şadıman Altınbaş Maternity and Women’s Health Teaching Research Hospital, Gynecologic Oncology Division, Ankara
  • Nurettin Boran Maternity and Women’s Health Teaching Research Hospital, Gynecologic Oncology Division, Ankara
  • Ömer Faruk Demir Maternity and Women’s Health Teaching Research Hospital, Gynecologic Oncology Division, Ankara
  • Mehmet Faruk Köse Maternity and Women’s Health Teaching Research Hospital, Gynecologic Oncology Division, Ankara

Keywords:

Uterine serous papillary carcinoma, Prognosis

Abstract

OBJECTIVE: The cases of 22 patients with uterine serous papillary carcinoma (USPC) were reviewed for this study.
STUDY DESIGN: The data of 22 patients diagnosed with USPC was examined. 18 patients underwent formal staging surgery including type I hysterectomy, bilateral salphingo-oophorectomy, para-aortic and bilateral pelvic lymphadenectomy, appendectomy and omentectomy in our clinic. Four patients were sent to our clinic from other hospitals after primary surgery. Staging of the disease was based on the
FIGO 1998.
RESULTS: At the time of diagnosis the median age was 62.2 years. The most common clinic complaint was vaginal bleeding (86.3%). seven patients were stage I (31.8%), one was stage II (4.5%), eight were stage III (36.3%) and six were stage IV (27.3%). Median disease-free survival was 25 months. Recurrence was not influenced by the stage of disease, lymphatic metastasis, depth of myometrial invasion, adjuvant therapy and the type of adjuvant treatment. However, the recurrence was influenced by positive cytology and invasion of omentum.
CONCLUSIONS: Staging surgery should be performed on patients with USPC. Invasion of omentum and positive cytology were poor prognostic factors. The effect of adjuvant therapy on prognosis is not clear.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Downloads

Published

2008-04-23

How to Cite

1.
Özbasar D, Bozok S, Turan T, Küçükelçi İltac, Tulunay G, Altınbaş Şadıman, Boran N, Demir Ömer F, Köse MF. Uterine Serous Papillary Carcinoma: A Retrospective Analysis of 22 Cases. Gynecol Obstet Reprod Med [Internet]. 2008Apr.23 [cited 2022Jul.5];14(1):30-5. Available from: https://gorm.com.tr/index.php/GORM/article/view/426

Issue

Section

Gynecology and Gynecological Oncology

Most read articles by the same author(s)

1 2 > >>